SCHEDULE 13G/A: Capital World Investors Discloses 9.6% Stake in Exact Sciences Corp.

Capital World Investors has filed an amended Schedule 13G, revealing a beneficial ownership of 9.6% of Exact Sciences Corp.'s common stock as of March 31, 2025.

Summary

• Capital World Investors, an investment adviser, has filed a Schedule 13G/A with the SEC regarding its beneficial ownership in Exact Sciences Corp.
• As of March 31, 2025, Capital World Investors beneficially owns 17,835,277 shares of Exact Sciences Corp. Common Stock.
• This ownership represents 9.6% of the total outstanding shares of Exact Sciences Corp., which are believed to be 185,755,406.
• Capital World Investors holds sole voting power over 17,828,104 shares and sole dispositive power over 17,835,277 shares.
• The filing indicates that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
• The Growth Fund of America is identified as a person known to have the right to receive or direct the receipt of dividends or proceeds from the sale of these securities.

Sentiment

Score: 7

Explanation: The filing of a Schedule 13G by a major institutional investor like Capital World Investors, indicating a significant stake (9.6%), is generally viewed positively as it suggests confidence in the company's value and prospects. However, as a routine ownership disclosure, it does not inherently convey strong positive or negative sentiment about the company's operational performance.

Future Outlook

This document is a beneficial ownership report and does not contain forward-looking statements or guidance regarding the issuer's future performance or outlook.

Industry Context

Exact Sciences Corp. operates in the healthcare and diagnostics industry, primarily known for its cancer screening and diagnostic tests. The disclosure of a significant stake by a major institutional investor like Capital World Investors can be viewed as a vote of confidence in the company's long-term prospects within its sector.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional holding by Capital World Investors may instill confidence among existing shareholders and potentially attract new investors, signaling institutional belief in the company's value.

Key Dates

Keywords

Exact Sciences Corp., Capital World Investors, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Healthcare, Diagnostics, Investment Adviser